Sign in
4

Changes in Ownership

GeneDx Holdings Corp. Filed Acc 0001944119-26-000037

CHIEF FINANCIAL OFFICER sold 3,728 shares at an average $97.61 ($363,892)

  • CHIEF FINANCIAL OFFICER acquired 7,197 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Feeley Kevin · CHIEF FINANCIAL OFFICER

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-16 Exercise or conversion : show line 1 in the form +7,197 48,673 D
2026-09-16 Sale : show line 2 in the form −586 $94.26 $55,235 48,087 D
2026-09-16 Sale : show line 3 in the form −52 $95.41 $4,961 48,035 D
2026-09-16 Sale : show line 4 in the form −541 $96.90 $52,423 47,494 D
2026-09-16 Sale : show line 5 in the form −1,470 $98.27 $144,457 46,024 D
2026-09-16 Sale : show line 6 in the form −1,079 $99.00 $106,816 44,945 D
Open-market sales · 3,728 sh · avg $97.61 · $363,892

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-16 Exercise or conversion : show line 7 in the form Restricted Stock Unit −7,197 14,393 D
Loading xslF345X06/form4-09182026_080909.xml…